Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response